Agonist potency at P2X7 receptors is modulated by structurally diverse lipids. - Wikidata - awgldk - TriplyDB

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

http://www.wikidata.org/entity/Q39321549

about

Cloning and pharmacological characterization of the dog P2X7 receptor.Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells Plasma membrane cholesterol as a regulator of human and rodent P2X7 receptor activation and sensitization.Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation.Activation and regulation of purinergic P2X receptor channels Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages.Allosteric modulation of ATP-gated P2X receptor channels The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells.Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes.Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7.Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects Negative and positive allosteric modulators of the P2X(7) receptor.The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells.Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation.

P2860

Q33509374-CDC3DBB0-AD2F-48C0-958C-95945D1FA725 Q33801926-63B3F8C6-72A0-4B1C-A9A6-3995F6D7A800 Q33948890-C41F28BE-D964-4719-B538-BB4F5ED63512 Q34509716-5F6EFAEF-278E-460C-9BCB-90C235CF7298 Q34680399-38B1D371-417C-4CC7-B6C3-737D265E8E24 Q35122793-11C38F1B-2CE9-4474-A76E-BEC53A0888BA Q35214735-372E3413-B5B1-41B8-BE11-A0C36D8CE5E5 Q36379060-5C085CF9-2AB4-4D7E-BB77-29FCBB7E9DD4 Q36825825-BBF978D7-2C8D-472B-BF49-F597BC5FEB12 Q37142680-F797B583-8F3D-4C83-ACFB-B0CBAD5AE6E6 Q37401620-C585C8C7-6319-4028-A08F-B631191FE37E Q38936183-B91FBF68-5490-49FC-AA75-15E1C3CA01D1 Q39708017-62195DB3-4C24-47AE-84DA-98FEF090EBBE Q39956832-BA73B37B-7E81-4FD3-97A1-1A7CB0A09B17 Q40037039-471C4727-3FFD-4C70-9B8D-8046C42360C3 Q40235535-53D1D6E6-E1FA-4312-B7CE-480890FF065B Q42363539-32F89062-6913-40EB-8E48-223A74AEDCC7

P2860

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

http://www.wikidata.org/entity/Q39321549

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@en

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@nl

type

label

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@en

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@nl

prefLabel

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@en

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@nl

P1433

Q39321549-6AD6EA25-1BF4-4BB6-B00E-CDC002CCB9E2

P1476

Q39321549-1B90F7BF-BFC9-4AE0-9CE5-5B4939367738

P2093

Q39321549-912D89F2-A57C-49A0-84D1-799490F83786

Q39321549-BD1BF3B7-5218-49EA-895C-257A9A1F17B7

P2860

Q39321549-08BECFDD-38D3-4136-A1A8-02F1C583245A

Q39321549-0DE63AC7-660A-4ED9-822E-414B0CBBAE9F

Q39321549-0DEFD975-1C39-442D-917B-D0926428E3D3

Q39321549-0F8AEB4A-A356-4A5A-A112-7A8D2B23F964

Q39321549-1B9630B1-BEA8-4EB0-B2D0-83449B78B82E

Q39321549-27C87F47-9102-4C3B-A33C-0C5B5AFD955B

Q39321549-2859F5B6-993E-4C07-96B7-F7279AA1C6B3

Q39321549-2C1BA79C-69CB-402E-B951-B47D8CD2DA96

Q39321549-2F7096D5-1B12-4F71-B0CC-3A7A47FCAC33

Q39321549-3106D09D-0CE8-4024-9ACD-5FA8D8E92B31

P304

Q39321549-354ED7BA-2667-4520-8A7D-CF00890F7374

P31

Q39321549-513B89F9-0EAC-4A60-9956-499658016FB3

P356

Q39321549-27FD5DB8-DA1A-4262-B671-14D1098D327E

P407

Q39321549-60AAF23A-1C00-4902-AE8B-7A345CE77135

P433

Q39321549-D7347C8B-C5F1-432A-84AE-CA88E7665814

P478

Q39321549-5886A7CD-8709-4861-8334-751C267E93E0

P577

Q39321549-D80D1A50-3FA3-403E-AB92-72A072588691

P5875

Q39321549-CF281129-B2D3-4679-856D-3FDB37E565F3

P698

Q39321549-41DEA278-F035-41AE-A3A8-63B30592A69F

P932

Q39321549-F2320255-381A-4F7F-9693-83BDC3FC4FEA

P356

P1433

British Journal of Pharmacology

P1476

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

@en

P2093

A D Michel

http://www.w3.org/2001/XMLSchema#string

E Fonfria

http://www.w3.org/2001/XMLSchema#string

P2860

Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor

Proteomic and functional evidence for a P2X7 receptor signalling complex

Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol

Molecular physiology of P2X receptors

Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction

The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.

Receptors for protons or lipid messengers or both?

P304

523-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0707417

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6138469

http://www.w3.org/2001/XMLSchema#string

P698

17700717

http://www.w3.org/2001/XMLSchema#string

P932

2050815

http://www.w3.org/2001/XMLSchema#string